Introduction
Coronary heart disease and diabetes mellitus are closely linked.' In general, the risk of coronary heart disease is increased 2-to 6-fold in diabetic subjects. [2] [3] [4] In countries such as the United Kingdom, where atherosclerotic vascular disease remains common, diabetes frequently accompanies coronary heart disease, and is often undiagnosed in its early stages. 56 In addition, diabetic myocardial infarction is associated with a poorer prognosis and twice the mortality of non-diabetic cases.5 '7 In countries such as Japan, where, in general, coronary heart disease is much less common, the presence of diabetes still confers at least double the risk of a subsequent myocardial infarction. 8 It is important to recognize that additional causes ofcardiac disease may be present in diabetes which compound the effects ofcoronary atheroma. Hypertension and cardiac microangiopathy are recognized complications of diabetes, and these in part explain why cardiac failure is observed with disproportionate frequency in diabetic patients.9
Autonomic cardiovascular dysfunction may compromise inotropic and chronotropic function and postural hypotension might 'tip the balance' in cases of critical coronary ischaemia. Indeed, the development of symptomatic autonomic neuropathy is associated with a grave prognosis, with cardiovascular causes ofdeath frequently responsible for the 60% 5-year mortality rates.'0 Less commonly, antecedents of both diabetes and cardiac disease, such as haemochromatosis and endocrine pathology (thyrotoxicosis, acromegaly and phaechromocytoma), or the coexistence of other conditions and their treatment (such as cor pulmonale and steroid treatment), may complicate the issue.
In trying to elaborate mechanisms which might explain why coronary heart disease is so common in diabetes, it is worth bearing in mind the complex nature of atherosclerosis and its thrombotic sequelae. Diabetes may be implicated at different stages of the process, from the initial intimal injury, to the point of smooth muscle proliferation, development of the mature atheromatous plaque, and, finally, vessel occlusion by thrombus.
At present, the prevention of cardiovascular disease has been the focus of much attention. The concept of 'risk factors' (or markers) has been applied to the general population to allow detection and treatment of individuals at 'high risk'. Tobacco consumption, and elevated levels ofblood pressure and concentrations of serum cholesterol are the clearest modifiable risk factors, although in themselves they are relatively poor discriminators of individual risk." In fact, the majority of cases of myocardial infarction have serum cholesterol concentrations less than 6.5 mmol/l,'2 although active lipid-lowering treatment is usually only advocated above this level.'3 Initiatives to reduce the average serum cholesterol of the population would require major central government funding which does not appear forthcoming at present. We therefore need to identify those at highest risk with greater accuracy.
The presence of diabetes itself enhances the cardiovascular risk attributed to smoking, blood pressure or cholesterol 2-fold, for reasons that are not fully apparent.'4"5 The prevalence of hypertension appears greater amongst the diabetic population. ' Peripheral hyperinsulinaemia is a feature of insulin-treated IDDM and NIDDM, and possibly also early NIDDM. Cross-sectional studies have demonstrated increased endogenous insulin reserve (assessed by C-peptide) in addition to increased insulin requirements in insulin-treated NIDDM with CHD in comparison to those without CHD.74 Although these findings were independent of body mass and age, multivariate analysis taking account of HDL and triglycerides was not carried out, so the role of insulin remains uncertain. It is also extremely difficult to separate the effect of hyperinsulinaemia from insulin resistance (better termed insensitivity) in these studies. Insulin insensitivity has, in fact, been estimated in a prospective study in IDDM and shown to predict CHD,76 although again this is not necessarily directly attributable to insulin, and might mark out those individuals with a tendency to dyslipoproteinaemia and/or hypertension.
Conclusion
Diabetes mellitus is associated with multiple metabolic, haemorheological and haemodynamic abnormalities which may together conspire to make the hyperglycaemic individual especially vulnerable to atherosclerotic coronary heart disease. Efforts to reduce the excessive mortality from CHD should concentrate on those in whom 'risk markers' cluster, particularly those with albuminuria or 'syndrome X'. 
